+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future

Cellular Reprogramming 19(4): 217-224

The concept of Regenerative Medicine combined with Cell based Therapy and Tissue Engineering represents the fourth pillar of healthcare and provides a promising approach for the treatment of serious diseases. Recently, cell based therapies are focused on the use of mesenchymal stem/stromal cells (MSCs). Human MSCs, that represent a mesoderm derived population of progenitors, are easily expanded in culture. They are capable to differentiate into osteoblasts, chondrocytes, and adipocytes and exhibit the potential to repair or regenerate damaged tissues. The best characterized source of human MSCs to date is the bone marrow; recently, fetal sources, such as amniotic fluid, umbilical cord, amniotic membranes, or placenta, have also attracted increased attention. Thus, MSCs may represent a valuable tool for tissue repair and cell therapeutic applications. To this end, the main focus of this review is to summarize and evaluate the key characteristics, the sources, and the potential use of MSCs in therapeutic approaches and modalities.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059959928

Download citation: RISBibTeXText

PMID: 28520465

DOI: 10.1089/cell.2016.0062

Related references

Secretome of mesenchymal stem/stromal cells in regenerative medicine. Biochimie 95(12): 2195, 2013

Mesenchymal stromal cells: past, present, and future. Veterinary Surgery 40(2): 129-139, 2011

Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering. Stem Cells International 2018: 8031718, 2018

Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. Bio-Medical Materials and Engineering 28(S1): S57-S63, 2017

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?. Transfusion Medicine and HemoTherapy 43(4): 256-267, 2016

Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Engineering. Part C Methods 16(6): 1515-1521, 2010

Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis. Medecine Sciences 34(12): 1092-1099, 2018

Mesenchymal Stem Cells: The Past, the Present, the Future. Cartilage 1(1): 6-9, 2010

Basic science of regenerative biology and application to regenerative medicine: Past, present, and future. Techniques in Regional Anesthesia and Pain Management 19(1-2): 3-9, 2015

Study on viability and chondrogenic differentiation of cryopreserved adipose tissue-derived mesenchymal stromal cells for future use in regenerative medicine. Cryobiology 71(2): 256-263, 2015

Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?. Langenbeck's Archives of Surgery 396(4): 489-497, 2011

Adipose-derived mesenchymal stem cells: past, present, and future. Aesthetic Plastic Surgery 33(3): 271-273, 2009

Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. Biomed Research International 2015: 430847, 2015

Regenerative Sports Medicine: Past, Present and Future. Pm & R, 2018

Biphasic Polyurethane/Polylactide Sponges Doped with Nano-Hydroxyapatite (nHAp) Combined with Human Adipose-Derived Mesenchymal Stromal Stem Cells for Regenerative Medicine Applications. Polymers 8(10):, 2016